Please login to the form below

Valid Insight to contribute to Advanced Master’s in Biotechnology & Pharmaceutical Management programme

At Valid Insight, we’re pleased to announce that in May 2020, we’ll be providing a series of specialist Market Access lectures as part of the Advanced Master’s in Biotechnology & Pharmaceutical Management programme with Grenoble Ecole de Management, a leading French graduate business school.

Thanks to our TRAVELLESS™ solution, our trusted virtual platform that we have been using for over two years to run web-based client advisory board meetings, at this time of travel restriction we will be delivering the entire lecture series online to ensure continuity for the students on this 15-month course.

The curriculum and course content for this program is designed to build knowledge, practical and management skills needed for future careers within the life sciences and pharmaceutical industry.

The course offers ability to gain real-world business skills by alternating between academic study and practical work placements. This balance between online courses and hands-on experience, enables students to learn from both academics and senior business professionals with deep industry experience, enhancing their business skills and building their professional networks.

We are pleased to have been invited to support this academic course and look forward to sharing our market access expertise and experience as part of the programme!

This news story, was originally posted here.

13th April 2020

Share

Tags

Company Details

Valid Insight

+44 (0) 20 3750 9833

Contact Website

Address:
152-160 City Road
Kemp House
London
EC1V 2NX
United Kingdom

Latest content on this profile

Webinar: How to develop an optimal value story for your product
This webinar is part of the ongoing expert insights series run by Valid Insight
Valid Insight
Last chance to register - Webinar: How to price a pharmaceutical product during a global economic recession
How can you ensure your product achieves optimal market access during a global economic recession?
Valid Insight
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen.
Valid Insight
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative to alternative treatments for successful market access. In this blog, we summarise the reasons for negative reimbursement decisions in 2017 and discuss common pitfalls manufacturers should avoid.
Valid Insight
Using TRAVELLESS™ to provide tailored pharmaceutical training
In May 2020, Valid Insight were scheduled to travel to Grenoble to deliver the market access modules as part of the Advanced Master’s in Biotechnology & Pharmaceutical Management programme with Grenoble Ecole de Management, a French graduate business school. The course has participants from varied backgrounds, but all from roles within the pharmaceutical industry.
Valid Insight
The vicious circle of pharmaceutical tendering
Pharmaceutical tendering and contracting has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s. In the 1990s, international institutions such as the World Health Organisation and the World Bank endorsed tendering as the preferred procurement process for drugs.
Valid Insight